agence france-presse
click here to return to agence france-presse main menu
DonateNow



AIDS vaccine researchers appeal for boost in global funding

Agence France-Presse - August 30, 2004


GENEVA, Aug 30 (AFP) - Some 800 researchers gathered for an international AIDS conference in Switzerland called on Monday for up to 15 billion dollars (12.5 billion euros) over the next decade to develop a vaccine against AIDS.

The scientists attending the AIDS Vaccine 2004 Conference in Lausanne appealed in a communique for "an increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines."

They estimated that it would take 10 to 15 billion dollars for the clinical development of existing vaccine candidates.

The appeal comes ten days after the United States threatened to withhold its contribution to the Global Fund to Fight AIDS unless other countries paid in at least 1.1 billion dollars.

Since it was created in 2002, the Global Fund to Fight AIDS has raised about three billion dollars instead of the 30 billion dollars projected.

040830
AF040894


©AFP 2004.. All Rights Reserved. AFP articles contained on the AEGiS web site may not be reproduced, distributed, transmitted, displayed, published or broadcast without AFP's prior written permission. You may make one copy of each article for your personal, non-commercial use only; more copies would require AFP's prior written permission.  http://www.afp.com/

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, Elton John AIDS Foundation, the National Library of Medicine, Bridgestone Firestone Trust Fund and donations from users like you. Always watch for outdated information. This article first appeared in 2004. This material is designed to support, not replace, the relationship that exists between you and your doctor.

©1990, 2004 - AEGiS. AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.